Charles Schwab Investment Management Inc Edgewise Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 522,086 shares of EWTX stock, worth $15.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
522,086
Previous 571,197
8.6%
Holding current value
$15.5 Million
Previous $10.3 Million
35.45%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding EWTX
# of Institutions
191Shares Held
100MCall Options Held
2.17MPut Options Held
410K-
Orbimed Advisors LLC San Diego, CA15MShares$445 Million9.45% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$264 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$178 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$173 Million1.67% of portfolio
-
Novo Holdings Hellerup, G75.55MShares$164 Million10.36% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.87B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...